The FDA has approved Miudella, a hormone-free copper IUD, for pregnancy prevention for up to three years, marking the first approval of a new copper IUD in the U.S. in over 40 years.
Chronic hepatitis B significantly reduces ovarian reserve in women undergoing in vitro fertilization, with researchers noting that hepatitis B surface antigen positivity should be considered a significant factor in infertility evaluations.